Ritedose, a sterile contract manufacturing organisation, is expanding its manufacturing facility with a seventh ...

Anticipating a rising need for individually wrapped vial medication manufacturing, The Ritedose Corporation, Inc. (Ritedose) ...

Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for ...

When pressed for 2025 expectations, Verona believed $254 million in revenues was a fair estimate. Critically, Verona expects ...

1 Day VRNA -7.21% DJIA -5.50% S&P 500 -5.97% Health Care/Life Sciences 4.56% ...

Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs.

Verona Pharma reported impressive fourth-quarter results, with revenue reaching $35.65 million, significantly exceeding analyst estimates of $6.14 million. This strong performance was driven by the ...

Verona Pharma is a biopharmaceutical company ... of chronic respiratory diseases with significant unmet medical needs. Ohtuvayre™ (ensifentrine) is the Company’s first commercial product ...